Lecciones del mundo real: Tratamiento del cáncer de mama de alto riesgo HR+/HER2− de acuerdo con los últimos datos

Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence Authors: Nadia Harbeck, MD, PhD; Stephen Johnston, MA, FRCP, PhD; Sara Tolaney, MD, PhD https://www.medscape.org/viewarticle/lessons-real-world-treating-high-risk-hr-her2-breast-cancer-2026a1000bhd?page=3&subtitle-lang-code=es&ecd=mkm_ret_260606_mscpmrk-ES_CME_etid8393469&uac=148436CN&impID=8393469